Ally Bridge Group (NY) LLC
Source: SEC Form 13F · as of Mar 2026Ally Bridge Group (NY) LLC holds 24 biotech & pharma companies tracked by BioSniper, totaling $108.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$108.6M
| Company | Shares | Value |
|---|---|---|
| SLNOSOLENO THERAPEUTICS INC | 400,000 | $13.4M |
| PRAXPraxis Precision Medicines, Inc. | 32,810 | $10.6M |
| OVIDOvid Therapeutics Inc. | 2,818,459 | $6.3M |
| CMPSCOMPASS Pathways plc | 1,045,000 | $5.8M |
| TARSTarsus Pharmaceuticals, Inc. | 80,859 | $5.7M |
| SLDBSolid Biosciences Inc. | 766,974 | $5.5M |
| CMPXCompass Therapeutics, Inc. | 1,000,000 | $5.3M |
| EWTXEdgewise Therapeutics, Inc. | 161,000 | $5.1M |
| QUREuniQure N.V. | 300,000 | $4.9M |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | 660,375 | $4.8M |
| CTMXCytomX Therapeutics, Inc. | 900,000 | $4.2M |
| IVAInventiva S.A. | 745,300 | $4.1M |
| CATXPerspective Therapeutics, Inc. | 926,557 | $3.9M |
| ABVXAbivax SA | 33,712 | $3.8M |
| ALMSALUMIS INC. | 166,959 | $3.7M |
| URGNUroGen Pharma Ltd. | 202,124 | $3.6M |
| CAPRCAPRICOR THERAPEUTICS, INC. | 113,899 | $3.5M |
| MAZEMaze Therapeutics, Inc. | 100,000 | $3.0M |
| WHWKWhitehawk Therapeutics, Inc. | 817,939 | $2.8M |
| IKTInhibikase Therapeutics, Inc. | 1,325,000 | $2.2M |
| REPLReplimune Group, Inc. | 246,900 | $1.9M |
| ANTXAN2 Therapeutics, Inc. | 526,315 | $1.8M |
| RLMDRELMADA THERAPEUTICS, INC. | 210,525 | $1.5M |
| KPTIKaryopharm Therapeutics Inc. | 250,000 | $1.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.